埃索美拉唑和雷贝拉唑哪个好

(Nexium) magnesium enteric-coated tablets are drugs used to treat gastroesophageal diseases, while rabeprazole sodium enteric-coated capsules are also suitable for gastrointestinal diseases. Therefore, many people will compare esomeprazole magnesium (Nexium) enteric-coated tablets and rabeprazole sodium enteric-coated capsules. Today we will take a closer look at which is better, esomeprazole or rabeprazole?

The active ingredient of Esomeprazole (Nexium) Magnesium Enteric-Coated Tablets is esomeprazole magnesium. Esomeprazole (Nexium) is the S-isomer of omeprazole. It reduces gastric acid secretion through a specific targeting mechanism and is a specific inhibitor of proton pumps in parietal cells. Esomeprazole magnesium enteric-coated tablets are suitable for the treatment of gastroesophageal reflux disease (GERD), erosive reflux esophagitis, and long-term maintenance treatment to prevent recurrence of cured esophagitis patients.

To explore the effect of esomeprazole (Nexium) combined with rabeprazole in the treatment of patients with gastroesophageal reflux disease and evaluate its prognostic impact. Methods: Select the general information of all patients with gastroesophageal reflux disease admitted between December 2016 and December 2018, and select 76 of them according to the requirements of this experiment The study was included in the experiment and divided into two groups by random grouping method, named control group (n=38) and study group (n=38). Patients in the control group were treated with rabeprazole, while patients in the study group were treated with esomeprazole combined with rabeprazole. The treatment effects of the two groups of patients were compared and their prognosis recovery was evaluated.

Results: The experimental results showed that the gastric mucosal recovery rate of the patients in the research group was 89.38% (34/38), while the gastric mucosal recovery rate of the patients in the control group was 65.79% (24/38). The data difference was statistically significant (P<0.05). And the experimental results showed that the total effective rate of treatment for the patients in the research group, data Compared with the control group, the difference was significant in data comparison analysis (P<0.05). Conclusion: The application of esomeprazole (Nexium) combined with rabeprazole in the treatment of patients with gastroesophageal reflux disease can effectively improve the patient's therapeutic effect and help improve the patient's gastric mucosal recovery rate. It has good application value and is worthy of promotion and use.

In a clinical comparative study of esomeprazole (Nexium) and omeprazole in the treatment of reflux esophagitis, the total effective rate of esomeprazole was 97.18%, which was significantly higher than 84.51% of omeprazole, and there was no significant difference in the incidence of adverse reactions. Chen Caiming has done a cost-effectiveness analysis of omeprazole and esomeprazole in the treatment of duodenal ulcer. The recovery rate of the esomeprazole (Nexium) group was 92.6%, which was higher than the 78.6% of omeprazole. The results proved that esomeprazole has cost and effectiveness advantages. 

The above is the content of (Nexium) effect, I hope it can help you!

Recommended related hot articles: /newsDetail/71942.html